Simulations Plus Extends its Distributor Agreement in Japan with Northern Science Consulting for Monolix™
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be presenting at Oppenheimer’s 32nd Annual Healthcare Conference taking place virtually from March 15-16, 2022.
Shawn O’Connor, chief executive officer, will present on Tuesday, March 15, 2022, at 4:00 p.m. ET. In addition, Mr. O’Connor will be available to host one-on-one meetings throughout the day. To listen to the live event or request a one-on-one meeting, please contact your Oppenheimer representative. The Company’s slide presentation will be available on the Investors page of the Simulations Plus website following the presentation.
For more information about the Oppenheimer Annual Healthcare Conference, or to register to attend, please visit the conference website.